TYLVALOSIN TARTRATE
UNII AL5667FY0W

Substance Identification & Data

This profile provides standardized clinical and technical data for Tylvalosin Tartrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AL5667FY0W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63428-13-7 and the RxNorm Concept ID (RxCUI) 1368468. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AL5667FY0W

CAS Registry Number

63428-13-7

RxNorm Concept ID

1368468

Detailed Substance Profile

Preferred Name

TYLVALOSIN TARTRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

AL5667FY0W

The specific atomic composition represented as a molecular structure string.

InChIKey

C53H87NO19.C4H6O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OLLSDNUHBJHKJS-XKORHJEPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152788

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

56840638

Unique identification number in the NCBI database of chemical substances.

USAN ID

UU-50

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1(OC[C@@H]\2[C@H](OC(C[C@H]([C@@H]([C@H]([C@H](C[C@H](C(/C=C/C(=C2)/C)=O)C)CC=O)O[C@@]3(O[C@@H]([C@H]([C@@H]([C@H]3O)N(C)C)O[C@]4(C[C@@](C)(O)[C@H]([C@@H](O4)C)OC(=O)CC(C)C)[H])C)[H])C)OC(=O)C)=O)CC)[C@@H]([C@@H]([C@@H]([C@H](O1)C)O)OC)OC.C([C@@H]([C@@H](O)C(O)=O)O)(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tylvalosin Tartrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.